Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin in Diabetic Decompensated Heart Failure
NCT04385589Phase 4Completed
- Sponsor
- Assiut University
- Start
- May 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin in acute decompensated heart failure (ADHF), sponsored by Assiut University. Started May 2020; status: completed.
02
Drugs
dapagliflozin
03
Conditions
acute decompensated heart failure (ADHF)
Beyond the preview
Go deeper on NCT04385589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04385589.